ORIC Pharmaceuticals (4TZ.F) Q2 2026 Earnings

4MayConfirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-0.45
-0.39
-0.33
-0.27

Details

Expected EPS
-0.27433897188
Actual EPS
-0.29080540000000005
Surprise EPS
-0.02
Surprise Percent
+6%

Description

ORIC Pharmaceuticals (4TZ.F) has reported earnings of -0.29080540000000005 per share for Q2 2026.

0 Comments

Share your thoughts